Concepedia

Dirk Garmann

DG

Statistics

Publications

17

Citations

605

H-Index

14

Active since

2004

Affiliations

Bayer (Germany)(Current)

University of Bonn

Bayer (United States)

McMaster University

University of Florida

Dirk Garmann is an author at Bayer (Germany) specializing in pharmacology, population pharmacokinetics, and pharmacokinetics.

ORCID

Publications per year

2004–2023

17

Publications

17

Synthesis and Biological Activity of Water-Soluble Maleimide Derivatives of the Anticancer Drug Carboplatin Designed as Albumin-Binding Prodrugs

André Warnecke, Iduna Fichtner, Dirk Garmann et al. · Bioconjugate Chemistry · 2004 · 100 citations

, , +13

Cellular accumulation and cytotoxicity of macromolecular platinum complexes in cisplatin-resistant tumor cells

Dirk Garmann, André Warnecke, Ganna V. Kalayda et al. · Journal of Controlled Release · 2008 · 84 citations

, , +16

Integrated Population Pharmacokinetic Analysis of Rivaroxaban Across Multiple Patient Populations

Stefan Willmann, Liping Zhang, Matthias Frede et al. · CPT Pharmacometrics & Systems Pharmacology · 2018 · 67 citations · Full text

, , +15

Enhancing lipophilicity as a strategy to overcome resistance against platinum complexes?

Irina Buß, Dirk Garmann, M. Galanski et al. · Journal of Inorganic Biochemistry · 2011 · 43 citations

, , +10

Improved Pharmacokinetics with BAY 81-8973 Versus Antihemophilic Factor (Recombinant) Plasma/Albumin-Free Method: A Randomized Pharmacokinetic Study in Patients with Severe Hemophilia A

Anita Shah, Alexander Solms, Dirk Garmann et al. · Clinical Pharmacokinetics · 2016 · 39 citations · Full text

, , +16

1–5 of 17